Industry And FDA Question Key Heart Rhythm Society Recommendations
This article was originally published in The Gray Sheet
Executive Summary
Device industry stakeholders do not support a key recommendation from the Heart Rhythm Society that the National Cardiovascular Data Registry be modified to collect more patient follow-up data on the performance of implantable cardioverter defibrillators (ICDs) and pacemakers
You may also be interested in...
HRS Guidelines Could Improve External Defibrillator Surveillance
Companies that make automated external defibrillators should develop systems to track where their devices are stored and who is using them in order to improve recall efforts, say two leading electrocardiologists
HRS Guidelines Could Improve External Defibrillator Surveillance
Companies that make automated external defibrillators should develop systems to track where their devices are stored and who is using them in order to improve recall efforts, say two leading electrocardiologists
FDA Calls Customized Reporting Forms For Heart Devices “Impractical”
FDA will not act on a key recommendation from the Heart Rhythm Society that the agency develop a customized form for reporting adverse events involving implantable cardioverter defibrillators (ICDs) and pacemakers